{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:38:10Z","timestamp":1773995890968,"version":"3.50.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Suboptimal cortisol levels after ACTH stimulation have been recently reported in approximately 30% of patients with nonclassic congenital adrenal hyperplasia (NCCAH). There is little information on the role of genotype on cortisol secretion in NCCAH. The aim of this study is to investigate the association between genotype (i.e compound heterozygote for one mild and one severe\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      variant\n                      <jats:italic>vs<\/jats:italic>\n                      . homozygous for two mild variants) and peak cortisol response after ACTH stimulation in a pediatric population with NCCAH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Retrospective chart review to identify children with NCCAH who had 1)\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      genetic information 2) high dose ACTH stimulation test and 3) serum cortisol measurements by LC-MS\/MS. The cohort was divided into 2 groups mild\/mild (M\/M) genotype (mild variants associated with NCCAH include V281L, P30L, P453S) and mild\/severe (M\/S) genotype (severe variants associated with classic CAH include gene deletion, Q318X, R356W, In2G, I172N) and peak cortisol concentrations were compared. IRB approved.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort included 23 children \u2013 12 M\/M and 11 M\/S diagnosed at 6.6 years old (SD 3.6, range 0.25-15). Peak cortisol levels were lower in the M\/S group compared to M\/M (mean +\/- SD, 13.2 +\/- 3.3\n                      <jats:italic>vs<\/jats:italic>\n                      . 19 +\/- 3.6 mcg\/dL, p=0.001). The overall prevalence of adrenal insufficiency (AI) using cortisol cutoff of &amp;lt;15 mcg\/dL (based on recent literature) was 9\/23 (39%) and was higher in M\/S\n                      <jats:italic>vs<\/jats:italic>\n                      . M\/M (8\/11, 73%\n                      <jats:italic>vs<\/jats:italic>\n                      . 1\/12, 8%, p=0.003).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data suggest higher rates of suboptimal cortisol response in children with NCCAH who have mild\/severe genotype compared to mild\/mild.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1745992","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:23:40Z","timestamp":1773984220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-ACTH peak cortisol response is associated with genotype in children with nonclassic congenital adrenal hyperplasia"],"prefix":"10.3389","volume":"17","author":[{"given":"Allie N.","family":"Dayno","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa J.","family":"Kilberg","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Gonter","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gallop","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Squicciarini","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Montano","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Vogiatzi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children\u2019s Hospital of Philadelphia","place":["Philadelphia, PA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society* clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","article-title":"21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia","author":"Nimkarn","year":"2002","journal-title":"GeneReviews\u00ae [Internet]"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-020-00100-w","article-title":"Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"7","author":"Dorr","year":"2020","journal-title":"Mol Cell Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000369901","article-title":"Inadequate cortisol response to the tetracosactide (Synacthen\u00ae) test in non-classic congenital adrenal hyperplasia: An exception to the rule","volume":"83","author":"Stoupa","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad546","article-title":"Genotype-specific cortisol reserve in a cohort of subjects with non-classic congenital adrenal hyperplasia (NCCAH)","volume":"109","author":"Koren","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.10.014","article-title":"Genetics of congenital adrenal hyperplasia","volume":"23","author":"Krone","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3343","article-title":"Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort","volume":"98","author":"Krone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2163","article-title":"Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency","volume":"92","author":"Araujo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"bvab022","DOI":"10.1210\/jendso\/bvab022","article-title":"New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays","volume":"5","author":"Javorsky","year":"2021","journal-title":"J Endocr Soc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.09.014","article-title":"Size of treatment effects and their importance to clinical research and practice","volume":"59","author":"Kraemer","year":"2006","journal-title":"Biol Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3803\/EnM.2024.1894","article-title":"A contemporary approach to the diagnosis and management of adrenal insufficiency","volume":"39","author":"Charoensri","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf018","article-title":"Genetics in congenital adrenal hyperplasia due to 21-hydroxylase deficiency and clinical implications","volume":"9","author":"Concolino","year":"2025","journal-title":"J Endocr Soc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1745992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:23:41Z","timestamp":1773984221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1745992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":15,"alternative-id":["10.3389\/fendo.2026.1745992"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1745992","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"article-number":"1745992"}}